The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat early symptomatic Alzheimer's disease, drugmaker Eli Lilly said. The move ...
Sept. 24 (UPI) --In a finding that could change the way Alzheimer's disease is treated, researchers have identified a brain biomarker that could allow the condition to be detected decades before ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback